Biotech Snap

Biotech Snap

A daily 5-min biotech briefing

Latest news

Agomab and SpyGlass top a $1B IPO week & Bayer wins a blood thinner trial

Agomab and SpyGlass top a $1B IPO week & Bayer wins a blood thinner trial

Joachim Eeckhout, +1
Eikon makes a $381M IPO debut & Angitia raises $130M for dual-action bone builders

Eikon makes a $381M IPO debut & Angitia raises $130M for dual-action bone builders

Joachim Eeckhout, +1
The weight-loss industry has a new winner & a hair-loss company raises $256.3M in an IPO

The weight-loss industry has a new winner & a hair-loss company raises $256.3M in an IPO

Joachim Eeckhout, +1
The race for the next obesity blockbuster intensifies as Novo, Pfizer and Skye share results

The race for the next obesity blockbuster intensifies as Novo, Pfizer and Skye share results

Joachim Eeckhout, +1
Sanofi wins in Gaucher disease & GSK abandons a pioneering RNA editing drug

Sanofi wins in Gaucher disease & GSK abandons a pioneering RNA editing drug

Joachim Eeckhout, +1
AstraZeneca signs a massive $18B obesity deal & a bunch of pharmas clean their pipeline

AstraZeneca signs a massive $18B obesity deal & a bunch of pharmas clean their pipeline

Joachim Eeckhout, +1
Repertoire signs a $1.9B autoimmune disorders deal & Sanofi cleans its pipeline

Repertoire signs a $1.9B autoimmune disorders deal & Sanofi cleans its pipeline

Joachim Eeckhout, +1
A wave of hearing loss gene therapies & Boehringer advance a kidney drug into pivotal trial

A wave of hearing loss gene therapies & Boehringer advance a kidney drug into pivotal trial

Joachim Eeckhout, +1
Boehringer inks a €1.05B with Simcere & Roche shows what its weight-loss drug can do

Boehringer inks a €1.05B with Simcere & Roche shows what its weight-loss drug can do

Joachim Eeckhout, +1
Fortitude launches to combine ADCs with protein degraders & Sanofi takes a gamble with eczema

Fortitude launches to combine ADCs with protein degraders & Sanofi takes a gamble with eczema

Joachim Eeckhout, +1
Corvus' stock explodes on eczema pill results & Corxel raises $287 million for its oral GLP-1

Corvus' stock explodes on eczema pill results & Corxel raises $287 million for its oral GLP-1

Joachim Eeckhout, +1
Pfizer signs a $530M vaccine deal & Novo drops another cell therapy

Pfizer signs a $530M vaccine deal & Novo drops another cell therapy

Joachim Eeckhout, +1
FirstBack
12345678
Next Last